WellCare Cost of Complacency survey shows that seniors could benefit by reviewing their Medicare coverage. (Photo by Alex Wong/Getty Images)
A recently released survey of Medicare-eligible people, called The Cost of Complacency, may pique your interest especially as the deadline for Medicare open enrollment approaches (Note: December 7th is the last day to change or enroll in a plan).
The survey, sponsored by WellCare Health Plans (NYSE: WCG) and conducted by an independent research company, Kelton Global, shows that we seniors are not doing our due diligence when it comes to evaluating our Medicare coverage. It turns out that fewer than half of us (40%) review our Medicare plan to see if were getting the best deal and are enrolled in the right plan. And, only about a third of us compare different plans. In fact, we comparison shop more for our cable and Internet plan and homeowners/automotive insurance plan than we do for our health insurance plan, as 44% review the cable/internet plan and 46% review their homeowners/automotive insurance
Top Insurance Stocks To Invest In 2019: Reinsurance Group of America, Incorporated(RGA)
- [By Shane Hupp]
Westpac Banking Corp grew its holdings in shares of Reinsurance Group of America (NYSE:RGA) by 96.7% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 9,188 shares of the insurance provider’s stock after purchasing an additional 4,516 shares during the period. Westpac Banking Corp’s holdings in Reinsurance Group of America were worth $1,415,000 as of its most recent filing with the Securities and Exchange Commission.
- [By Ethan Ryder]
Prudential (NYSE: PUK) and Reinsurance Group of America (NYSE:RGA) are both finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, risk, profitability and institutional ownership.
- [By Logan Wallace]
Here are some of the media stories that may have effected Accern Sentiment’s rankings:
Get Reinsurance Group of America alerts:
Reinsurance Group of America (RGA) versus Its Peers Financial Contrast (americanbankingnews.com) Comparing Reinsurance Group of America (RGA) and The Competition (americanbankingnews.com) Head to Head Analysis: Reinsurance Group of America (RGA) versus Its Competitors (americanbankingnews.com) Reinsurance Group of America (RGA) versus The Competition Financial Survey (americanbankingnews.com) Reinsurance Group of America (RGA) EVP Timothy T. Matson Buys 300 Shares (americanbankingnews.com)
RGA has been the subject of a number of analyst reports. Wells Fargo restated a “market perform” rating and issued a $160.00 price target (up previously from $150.00) on shares of Reinsurance Group of America in a research report on Tuesday, January 9th. UBS initiated coverage on Reinsurance Group of America in a research report on Friday, March 2nd. They issued a “neutral” rating and a $168.00 price target for the company. Zacks Investment Research cut Reinsurance Group of America from a “buy” rating to a “hold” rating in a research report on Monday, March 12th. Morgan Stanley reduced their price target on Reinsurance Group of America from $138.00 to $135.00 and set an “underweight” rating for the company in a research report on Thursday, April 5th. Finally, Credit Suisse Group initiated coverage on Reinsurance Group of America in a research report on Wednesday, April 25th. They issued a “neutral” rating and a $164.00 price target for the company. One research analyst has rated the stock with a sell rating, six have issued a hold rating and two have issued a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $159.78.
Top Insurance Stocks To Invest In 2019: Alexion Pharmaceuticals, Inc.(ALXN)
- [By Brian Feroldi]
In response to the company reporting expectation-topping first-quarter results and sharing upbeat pipeline news, shares of Alexion Pharmaceuticals (NASDAQ:ALXN) jumped 12% as of 3:15 p.m. EDT on Thursday.
- [By Chris Lange]
Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) is scheduled to reveal its first-quarter results Thursday morning. The consensus forecast calls for EPS of $1.50 and $922.99 million in revenue. Shares were trading at $107.78 on Fridays close. The consensus price target is $158.60, while the 52-week range is $96.18 to $149.34.
- [By Lisa Levin] Gainers
Genprex, Inc. (NASDAQ: GNPX) shares gained 86.76 percent to close at $11.00 on Thursday.
Comstock Resources, Inc. (NYSE: CRK) shares climbed 47.06 percent to close at $7.00 after the company disclosed a deal with Arkoma Drilling L.P. and Williston Drilling, L.P. to buy oil & gas properties in North Dakota. Comstock announced withdrawal of tender offers for outstanding secured notes.
Ceridian HCM Holding Inc. (NASDAQ: CDAY) gained 41.86 percent to close at $31.21.
MarineMax, Inc. (NYSE: HZO) shares rose 26.5 percent to close at $22.20 as the company posted upbeat Q2 results and raised its FY18 outlook.
Concord Medical Services Holdings Limited (NYSE: CCM) jumped 24.92 percent to close at $4.06.
Mattersight Corporation (NASDAQ: MATR) shares climbed 23.26 percent to close at $2.65 after the company agreed to be purchased by NICE Ltd.
Chipotle Mexican Grill, Inc. (NYSE: CMG) rose 24.44 percent to close at $422.50 as the company reported stronger-than-expected results for its first quarter on Wednesday.
Ultra Clean Holdings, Inc. (NASDAQ: UCTT) gained 17.75 percent to close at $18.64 following upbeat Q1 earnings.
PCM, Inc. (NASDAQ: PCMI) rose 16.59 percent to close at $12.30 following Q1 results.
Zymeworks Inc. (NASDAQ: ZYME) rose 16.06 percent to close at $15.25.
Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) shares climbed 14.5 percent to close at $121.42 as the company posted reported Q1 beat And raised FY18 outlook.
Advanced Micro Devices, Inc. (NASDAQ: AMD) shares gained 13.7 percent to close at $11.04 as the company reported upbeat results for its first quarter.
Axsome Therapeutics, Inc. (NASDAQ: AXSM) rose 13.21 percent to close at $3.00 after the company disclosed a positive outcome of the interim analysis of STRIDE-1 Phase 3 trial of AXS-05 in treatment resistant depression.
O'Reilly Automotive, Inc. (NASDAQ: ORLY) jumped 13.06 percent to close at $257.40 following upbeat Q1 profit.
- [By Chris Lange]
Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) is breaking out from a bullish continuation pattern after completing a 2-year+ consolidation bottom. Upside is seen to the $200 area. Celgene Corp. (NASDAQ: CELG), Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN), and Incyte Corp. (NASDAQ: INCY) have weaker technical patterns and may have further downside risks. BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is forming a potential bearish top – a move below $77.98 would open $71 to the $60 area.
- [By ]
Alexion Pharmaceuticals Inc. (ALXN) is a U.S. pharma stock best known for its development of rare blood disorder drug Soliris. So far this drug has proved extremely successful. And now, the company is looking to expand into further treatment opportunities. The company is on the verge of snapping up Sweden’s Wilson Therapeutics for $855 million, further boosting (and diversifying) its rare disease lineup.
Top Insurance Stocks To Invest In 2019: 2U, Inc.(TWOU)
- [By Todd Campbell]
Investing in emerging growth stocks for the long haul can be a great way to produce market-beating returns, but with thousands of stocks to choose from, it can be tough figuring out which are worth owning. To help, I went searching for growth stocks that can be added to portfolios and pickedAtlassian Corp. (NASDAQ:TEAM), Mimecast (NASDAQ:MIME), and 2U Inc. (NASDAQ:TWOU) as my favorite stocks to buy in May. Read on to learn if these stocks are right for your portfolio, too.
- [By Steve Symington]
2U Inc.(NASDAQ:TWOU)announced first-quarter 2018 results on Thursday after the market closed, highlighting not only the strength of its core Graduate Program business, but also the growing influence of its short-course offerings following its acquisition of GetSmarter last year. Shares were up more than 6% on Friday as of this writing, so let’s settle in to learn more about what drove the online education-platform company this quarter, as well as what investors should be watching in the year ahead.
- [By Brian Withers]
2U Inc.’s (NASDAQ:TWOU) stock has had an amazing run since the company went public, up over 500% since the March 2014 IPO. The online education company posted stellar 2017 results and has continued robust revenue growth in Q1 2018 with 42% year-over-year growth. But the company still hasn’t posted a profit, with a net loss of $29.4 million in 2017, compared to a loss of $20.7 million in 2016. First-quarter results posted in early May showed a quarterly net loss of $14.9 million, and is the company projecting a full year net loss between $46.6 million and $44.7 million.